GammaTile® Marks Milestone: 100th Patient Enrolled in Groundbreaking ROADS Phase 3 Clinical Trial for Newly Diagnosed Metastatic Brain Tumors

Posted on by

Randomized Controlled Trial Targets Residual Cancer Cells during Brain Surgery with Implant Delivering Radiation, Aiming to Advance Local Control TEMPE, Ariz., April 9, 2024 /PRNewswire/ — GT Medical Technologies, Inc. (GT MedTech), a medical device company with the mission of improving…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.